These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31299805)

  • 41. Denosumab: a case of MRONJ with resolution.
    Lyttle CV; Patterson H
    Br Dent J; 2016 Jun; 220(12):623-5. PubMed ID: 27338901
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Case reports of medication-related osteonecrosis of the jaw (MRONJ) treated with uncultured stromal vascular fraction and L-PRF.
    Bouland C; Meuleman N; Widelec J; Keiani-Mothlagh K; Voisin C; Lagneaux L; Philippart P
    J Stomatol Oral Maxillofac Surg; 2021 Apr; 122(2):212-218. PubMed ID: 32540361
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is the conservative non-surgical management of medication-related osteonecrosis of the jaw an appropriate treatment option for early stages? A long-term single-center cohort study.
    Ristow O; Rückschloß T; Müller M; Berger M; Kargus S; Pautke C; Engel M; Hoffmann J; Freudlsperger C
    J Craniomaxillofac Surg; 2019 Mar; 47(3):491-499. PubMed ID: 30642734
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-RANKL Inhibits Thymic Function and Causes DRONJ in Mice.
    Nakamura Y; Kikuiri T; Sugiyama T; Maeda A; Izumiyama D; Yahata D; Yoshimura Y; Shirakawa T; Kitagawa Y
    Int J Dent; 2022; 2022():9299602. PubMed ID: 35464103
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of Leukocyte- and Platelet-Rich Fibrin in the Treatment of Medication-Related Osteonecrosis of the Jaws.
    Maluf G; Caldas RJ; Silva Santos PS
    J Oral Maxillofac Surg; 2018 Jan; 76(1):88-96. PubMed ID: 28675810
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of the Clinical Outcomes of Buccal Advancement Flap Versus Platelet-Rich Fibrin Application for the Immediate Closure of Acute Oroantral Communications.
    Bilginaylar K
    J Craniofac Surg; 2019 Jan; 30(1):e45-e49. PubMed ID: 30480627
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Bisphosphonate and denosumab-related osteonecrosis of the jaw: Epidemiology, diagnosis and management].
    Dupic G; Collangettes D; Dillies AF; Calvet L; Tournilhac O; Bay JO; Mahammedi H
    Bull Cancer; 2015 Dec; 102(12):1010-9. PubMed ID: 26607453
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of the centrifuge characteristics and centrifugation protocols on the cells, growth factors, and fibrin architecture of a leukocyte- and platelet-rich fibrin (L-PRF) clot and membrane.
    Dohan Ehrenfest DM; Pinto NR; Pereda A; Jiménez P; Corso MD; Kang BS; Nally M; Lanata N; Wang HL; Quirynen M
    Platelets; 2018 Mar; 29(2):171-184. PubMed ID: 28437133
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Denosumab-related osteonecrosis of the jaw: a case report and management based on pharmacokinetics.
    You Tm; Lee KH; Lee SH; Park W
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Nov; 120(5):548-53. PubMed ID: 26337218
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Medication-related osteonecrosis of the jaw associated with bisphosphonates and denosumab in osteoporosis.
    Bagan J; Peydró A; Calvo J; Leopoldo M; Jiménez Y; Bagan L
    Oral Dis; 2016 May; 22(4):324-9. PubMed ID: 26818808
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Successful Use of Leukocyte Platelet-Rich Fibrin in the Healing of Sinus Membrane Perforation: A Case Report.
    Pinto GDDS; Pigossi SC; Pessoa T; Nícoli LG; Araújo RFSB; Marcantonio C; Marcantonio E
    Implant Dent; 2018 Jun; 27(3):375-380. PubMed ID: 29461999
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Denosumab-associated osteonecrosis of the jaw--a case report.
    Vyas S; Hameed S; Murugaraj V
    Dent Update; 2014 Jun; 41(5):449-50. PubMed ID: 25073227
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of pedicled buccal fat pad in the closure of oroantral communication: analysis of 75 cases.
    Dolanmaz D; Tuz H; Bayraktar S; Metin M; Erdem E; Baykul T
    Quintessence Int; 2004 Mar; 35(3):241-6. PubMed ID: 15119684
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Maxillary osteonecrosis after denosumab treatment].
    Duininck JM; de Lange J; Rozema FR; Dubois L
    Ned Tijdschr Tandheelkd; 2018 Dec; 125(12):653-657. PubMed ID: 30560961
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Successful surgical management of osteonecrosis of the jaw due to RANK-ligand inhibitor treatment using fluorescence guided bone resection.
    Otto S; Baumann S; Ehrenfeld M; Pautke C
    J Craniomaxillofac Surg; 2013 Oct; 41(7):694-8. PubMed ID: 23830772
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of Platelet Rich Fibrin (PRF)-Based Autologous Membranes for Tooth Extraction in Patients under Bisphosphonate Therapy: A Case Report.
    Pispero A; Bancora I; Khalil A; Scarnò D; Varoni EM
    Biomedicines; 2019 Nov; 7(4):. PubMed ID: 31717656
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Can platelet-rich fibrin improve healing after surgical treatment of medication-related osteonecrosis of the jaw? A pilot study.
    Giudice A; Barone S; Giudice C; Bennardo F; Fortunato L
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Nov; 126(5):390-403. PubMed ID: 30108028
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Retrospective Observational Study of Risk Factors for Denosumab-Related Osteonecrosis of the Jaw in Patients with Bone Metastases from Solid Cancers.
    Okuma S; Matsuda Y; Nariai Y; Karino M; Suzuki R; Kanno T
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32408510
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current knowledge and perspectives for the use of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in oral and maxillofacial surgery part 2: Bone graft, implant and reconstructive surgery.
    Simonpieri A; Del Corso M; Vervelle A; Jimbo R; Inchingolo F; Sammartino G; Dohan Ehrenfest DM
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1231-56. PubMed ID: 21740370
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Osteonecrosis of the jaw induced by receptor activator of nuclear factor-kappa B ligand (Denosumab) - Review.
    de Oliveira CC; Brizeno LA; de Sousa FB; Mota MR; Alves AP
    Med Oral Patol Oral Cir Bucal; 2016 Jul; 21(4):e431-9. PubMed ID: 26827069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.